Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.
- DOI
- 10.1007/s10549-010-0989-6
- Published
- 2010 Aug
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-010-0989-6,
title = {Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.},
author = {Mansi JL and Yellowlees A and Lipscombe J and Earl HM and Cameron DA and Coleman RE and Perren T and Gallagher CJ and Quigley M and Crown J and Jones AL and Highley M and Leonard RC and Evans TR},
year = {2010},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-010-0989-6},
url = {https://doi.org/10.1007/s10549-010-0989-6}
}RIS
TY - JOUR TI - Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. AU - Mansi JL AU - Yellowlees A AU - Lipscombe J AU - Earl HM AU - Cameron DA AU - Coleman RE AU - Perren T AU - Gallagher CJ AU - Quigley M AU - Crown J AU - Jones AL AU - Highley M AU - Leonard RC AU - Evans TR PY - 2010 JO - Breast cancer research and treatment DO - 10.1007/s10549-010-0989-6 UR - https://doi.org/10.1007/s10549-010-0989-6 ER -
APA
JL, M., A, Y., J, L., HM, E., DA, C., RE, C., T, P., CJ, G., M, Q., J, C., AL, J., M, H., RC, L., & TR, E. (2010). Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-010-0989-6
Source records
- pubmed · retrieved 2026-09-25T23:59:14.429Z